Watson, Amneal, others oppose class certification in Colcrys US antitrust case
MLex Summary: Watson Laboratories, Amneal Pharmaceuticals, Par Pharmaceuticals, and Takeda opposed a motion to certify a proposed class of direct purchasers of Colcrys in a US antitrust case. They said that...To view the full article, register now.
Already a subscriber? Click here to view full article